Differential Clinical and Virologic Impact of Hepatitis B Virus Genotypes B and C on HIV-Coinfected Patients Receiving Lamivudine-Containing Highly Active Antiretroviral Therapy | Zendy

WangHuei Sheng | Zendy; ChienChing Hung | Zendy; SuiYuan Chang | Zendy; ChunJen Liu | Zendy; Mao-Yuan Chen | Zendy; SzuMin Hsieh | Zendy; JiaHorng Kao | Zendy; PeiJer Chen | Zendy; ShanChwen Chang | Zendy

Open Access

Differential Clinical and Virologic Impact of Hepatitis B Virus Genotypes B and C on HIV-Coinfected Patients Receiving Lamivudine-Containing Highly Active Antiretroviral Therapy

Author(s) -

WangHuei Sheng,

ChienChing Hung,

SuiYuan Chang,

ChunJen Liu,

Mao-Yuan Chen,

SzuMin Hsieh,

JiaHorng Kao,

PeiJer Chen,

ShanChwen Chang

Publication year - 2011

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir851

Subject(s) - lamivudine , medicine , hepatitis b virus , virology , hepatitis b , coinfection , genotype , sida , orthohepadnavirus , hepatitis c virus , virus , human immunodeficiency virus (hiv) , viral disease , immunology , hepadnaviridae , gene , biology , biochemistry

The impact of hepatitis B virus (HBV) genotypes B and C on the clinical, immunologic, and virologic outcomes of human immunodeficiency virus (HIV)-infected patients with chronic HBV infection remains largely unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research